检索

标题
作者
Updating approaches to patient management in the light of new European guidelines on arterial hypertension: analytical review
Larina V., Vartanyan E., Fedorova E., Mikhaylusova M., Sayno O., Mironova T.
Genotypic stratification of risk of acute cerebral circulation disorder
Nikulin D., Chernova A., Nikulina S., Prokopenko S., Mar'ina N.
National Medical Research Center for Preventive Medicine, Moscow, Russia
Evsyutina Y.
Heart lesions in individuals with arterial hypertension of various risk levels: the possibility of diagnosis and treatment
Britov A., Platonova E., Eliseeva N.
Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2)
Bubnova M.
Salt and hypertension. Possibilities of the non-drug prevention of hypertension by dietary correction in an organized population of 25-to-49-year-old men and women for 3 years
Molchanova O., Britov A., Andreeva G.
Perspektivy klinicheskogo primeneniyanovoy fiksirovannoy kombinatsii -preparata Ko-Eksforzh v lecheniiarterial'noy gipertonii
Bubnova M.
Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
Evdokimova A., Smetanin A., Evdokimov V., Kovalenko E., Kiyakbaeva E.
Effects of different doses of rosuvastatin on blood lipids and lipoproteins, endothelial function, and cerebral blood flow in patients with hyperlipidemia and cerebral ischemic stroke-complicated hypertension
Bubnova M., Semenova E., Aronov D., Batysheva T.
Chronic obstructive pulmonary disease and arterial hypertension: methaphysics and dialectic
Li V., Zadionchenko V., Adasheva T., Pavlov S., Shakhrai N.
The study of vascular wall stiffness in patients with arterial hypertension depending on some factors of risk and associated clinical conditions
Khaisheva L., Shlyk S., Samakaev A., Glova S., Pirozhenko A., Samokhina L.
Clinical efficacy of combined use of physical training and a fixed combination of an angiotensin receptor blocker II - valsartanumand the calcium antagonist - amlodipine on ambulatory (III) stage of rehabilitation in smoking patients with comorbid diseases (coronary heart disease, hypertension and chronic obstructive pulmonary disease)
Bubnova M., Sulim Y., Aronov D., Novikova N., Vygodin V., Meshcheryakova N.
Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part II
Bubnova M.
Clinical haracteristik and psychological profile of patients with arterial hypertension with high cardiovascular risk against the background of antihypertensive therapy with inhibitors of angiotensin converting enzyme (ACE)
Kaskayeva D., Petrova M., Kostina V., Evsyukov A., Tepper E.
The clinical efficacy of a fixed combination of angiotensin receptor blockers valsartan II with a calcium antagonist amlodipine - drug Exforge® smokers patients with cardiovascular disease and chronic obstructive pulmonary disease
Bubnova M., Aronov D., Sulim Y., Vygodin V.
Antihypertensive and pleiotropic activity of the calcium antagonist amlodipine in patients with arterial hypertension and obesity
Bubnova M., Aronov D., Kuznetsova I., Vygodin V.
ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1)
Bubnova M.
Arterial hypertension and chronic obstructive pulmonary disease: pathogenetic parallels and clinicofunctional features
Zadionchenko V., Adasheva T., Fedorova I., Pavlov S., Li V., Nesterenko O.
Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part I
Bubnova M.
Comprehensive medical rehabilitation program after percutaneous coronary intervention for acute myocardial infarction in patients with coronary heart disease and arterial hypertension: efficacy, safety, and the results of remote monitoring
Bubnova M., Aronov D., Krasnitskiy V., Novikova N., Matveeva I., Ioseliani D.
The role of the insulin-like factor of growth 1 in the development of the processes of myocardial remodeling in women with arterial hypertension and metabolic syndrome
Zakirova N., Nikolaeva I., Zakirova A., Nurtdinova E., Galiyeva E., Nizamova D.
The role of calcium antagonists in the treatment of cardiovascular disease: Focus on diltiazem
Baryshnikova G., Chorbinskaya S., Stepanova I.
The effectiveness of a two-component renin-angiotensin aldosterone system blockade after renal transplantation in patients with chronic terminal renal failure
Ostanina A., Fomin I., Polyakov D., Lipatov K., Shcherbakova G.
1 - 23 的 23 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##